Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-In-Human, Open-Label Trial to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of GEN1119 in Participants With Solid Tumors

NCT07695831 is registered in ClinicalTrials.gov with Genmab as lead sponsor.

NCT NCT07695831
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07695831 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-In-Human, Open-Label Trial to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of GEN1119 in Participants With Solid Tumors
Lead sponsor
Genmab
Phase
Phase 1
Overall status
Recruiting
Start date
August 13, 2026
Completion date
June 30, 2029
Enrollment
112 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumours